Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
Illner
W D
WD
Department of Surgery, Klinikum Grosshadern, Munich, FRG.
Theodorakis
J
J
Abendroth
D
D
Schleibner
S
S
Stangl
M
M
Landgraf
R
R
Land
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D016035:Pancreas Transplantation / Q000276:immunology*; D013256:Steroids / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D016853:Muromonab-CD3; D013256:Steroids; D001379:Azathioprine